Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Maintains Overweight on RingCentral, Raises Price Target to $404

Keybanc analyst Steve Enders maintains RingCentral (NYSE:RNG) with a Overweight and raises the price target from $390 to $404.

byBenzinga Newsdesk

November 10, 2021

1 minute read

Keybanc analyst Steve Enders maintains RingCentral (NYSE:RNG) with a Overweight and raises the price target from $390 to $404.

William Blair Initiates Coverage On Sight Sciences with Outperform Rating

By Benzinga Newsdesk

Today, 4:36 PM

William Blair initiates coverage on Sight Sciences (NASDAQ:SGHT) with a Outperform rating.

SGHT

Wynn Resorts To Develop Integrated Resort In Ras Al Khaimah, UAE

By Shivani Kumaresan

Today, 4:36 PM

Wynn Resorts Ltd (NASDAQ:WYNN), along with UAE property developer Marjan and RAK Hospitality Holding, plans a multibillion-dollar integrated resort development on…

WYNN

JP Morgan Maintains Overweight on Starbucks, Raises Price Target to $100

By Benzinga Newsdesk

Today, 4:36 PM

JP Morgan analyst John Ivankoe maintains Starbucks (NASDAQ:SBUX) with a Overweight and raises the price target from $92 to $100.

SBUX

AstraZeneca’s Once-Weekly Diabetes Med Wins FDA Nod For Use In Children

By Vandana Singh

Today, 4:36 PM

The FDA has approved AstraZeneca Plc’s (NASDAQ:AZN) Budureon BCise (exenatide extended-release), once-weekly injectable suspension for type 2 diabetes (T2D) in pediatric…

AZN

Keybanc Maintains Overweight on RingCentral, Raises Price Target to $404

Related Posts

William Blair Initiates Coverage On Sight Sciences with Outperform Rating

Wynn Resorts To Develop Integrated Resort In Ras Al Khaimah, UAE

JP Morgan Maintains Overweight on Starbucks, Raises Price Target to $100

AstraZeneca’s Once-Weekly Diabetes Med Wins FDA Nod For Use In Children